Med (Baltim) 102(46):e35951
Patients and Interventions/Exposure : New users of semaglutide (n= 613) and liraglutide (n=4,144), which are GLP-1 receptor agonists approved for diabetes, and users of buproprion-naltrexone (n= 654), an Federal Drug Administration (FDA)-approved weight loss agent, which served as active comparator
Mutations in the genes IDH1 and IDH2 , which also change how glutamine products are used in a cell, are common in certain types of brain cancer and leukemia
Theres a risk of putting the weight back on when you stop unless you maintain lifestyle changes, a healthy diet of whole foods, and regular exercise
Mutations in the CBS gene can cause disorders like Downs syndrome and peripheral neuropathy
These two classes of medication serve fundamentally different purposes: Mounjaro targets metabolic health and weight reduction, whilst anabolic steroids aim to increase muscle mass and physical performance